Literature DB >> 7964721

L-glutamate uptake inhibitors may stimulate phosphoinositide hydrolysis in baby hamster kidney cells expressing mGluR1a via heteroexchange with L-glutamate without direct activation of mGluR1a.

C Thomsen1, L Hansen, P D Suzdak.   

Abstract

The functional efficacies of inhibitors of L-glutamate uptake for altering second messenger formation in baby hamster kidney cells expressing subtypes mGluR1a, mGluR2, and mGluR4 of the metabotropic glutamate receptor family were examined. L-Serine-O-sulfate was an agonist at mGluR1a (EC50 = 70 microM), mGluR2 (EC50 = 25 microM), and mGluR4 (EC50 = 324 microM). L-Cysteine sulfinate, 1-aminocyclobutane-trans-1,3-dicarboxylate, L-cysteine, and DL-threo-3-methylaspartate stimulated phosphoinositide hydrolysis in mGluR1a cells with EC50 values of 43, 64, 463, and 488 microM, respectively, and displaced L-[3H]glutamate binding from membranes prepared from these cells with respective IC50 values of 48, 44, 79, and 139 microM. However, D-aspartate, L-trans-pyrrolidine-2,4-dicarboxylate, L-threo-3-hydroxyaspartate, and L-aspartate-beta-hydroxamate stimulated phosphoinositide hydrolysis in mGluR1a cells (respective EC50 values of 73, 54, 57, and 430 microM) but did not displace L-[3H]glutamate binding. These compounds inhibited Na(+)-dependent L-glutamate uptake into baby hamster kidney cells with IC50 values similar to those for stimulation of phosphoinositide hydrolysis in mGluR1a cells. Phosphoinositide hydrolysis in mGluR1a cells, as stimulated by inhibitors of (or substrates for) this L-glutamate transporter, was significantly attenuated in the presence of L-glutamate decarboxylase (EC 4.1.1.15) or L-alanine aminotransferase (EC 2.6.1.2). Furthermore, incubation with 1 mM L-trans-pyrrolidine-2,4-dicarboxylate for 30 min increased the basal levels of free glutamate (1.5 +/- 0.2 microM) in the assay buffer four- to fivefold as measured by HPLC analysis. Thus, heteroexchange with endogenous L-glutamate may lead to erroneous estimations of the functional efficacies at mGluR1a.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964721     DOI: 10.1046/j.1471-4159.1994.63062038.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  [3H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a.

Authors:  L Eriksen; C Thomsen
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Pharmacological characterization of desensitization in a human mGlu1 alpha-expressing non-neuronal cell line co-transfected with a glutamate transporter.

Authors:  M A Desai; J P Burnett; N G Mayne; D D Schoepp
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway.

Authors:  Stine Engesgaard Jacobsen; Ina Ammendrup-Johnsen; Anna Mai Jansen; Ulrik Gether; Kenneth Lindegaard Madsen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

4.  Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP.

Authors:  Jesper Mosolff Mathiesen; Nannette Svendsen; Hans Bräuner-Osborne; Christian Thomsen; M Teresa Ramirez
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

5.  Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer.

Authors:  C J Swanson; D A Baker; D Carson; P F Worley; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

6.  Effects of varying the expression level of recombinant human mGlu1alpha receptors on the pharmacological properties of agonists and antagonists.

Authors:  E Hermans; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine, and dopamine metabolites in the prefrontal cortex of the freely moving rat: involvement of NMDA and AMPA/KA receptors.

Authors:  A Del Arco; F Mora
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

8.  Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Authors:  E F Sharpe; A E Kingston; D Lodge; J A Monn; P M Headley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 9.  The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.

Authors:  C Clemmensen; S Smajilovic; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 10.  Molecular Basis for Modulation of Metabotropic Glutamate Receptors and Their Drug Actions by Extracellular Ca2.

Authors:  Juan Zou; Jason Y Jiang; Jenny J Yang
Journal:  Int J Mol Sci       Date:  2017-03-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.